Researchers Seek Drugs to Promote Remyelination in Progressive MS

Other investigators are working on developing small-molecule drugs that can stimulate remyelination. There is thus reason to be optimistic that the small-molecule approach to promoting remyelination will prove to be beneficial, said Dr. Bourdette. Providing a strong stimulus to the OPCs may allow them to overcome the toxic environment that they inhabit, he concluded.

—Erik Greb